Open-Label Safety Study of AXS-05 in Subjects With Alzheimer's Disease Agitation

Conditions:   Agitation in Patients With Dementia of the Alzheimer's Type;   Alzheimer Disease;   Agitation, Psychomotor Intervention:   Drug: AXS-05 (dextromethorphan-bupropion) Sponsor:   Axsome Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials